This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: GRPN RAX JAZZ PCLN MGM

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Cubist Pharmaceuticals (CBST) rated new Buy at Goldman. Stock also placed on the Conviction List. $54 price target. CXA will likely be the company's next big growth driver.

CVS Caremark (CVS) upgraded at BMO from Market Perform to Outperform, BMO Capital said. $53 price target. Company should see improved margins and earnings power in the coming quarters.

Dril-Quip (DRQ) downgraded at BofA/Merrill from Buy to Underperform, Bank of America/Merrill Lynch said. Valuation call, based on a $79 price target.

FirstEnergy (FE) downgraded at UBS to Neutral from Buy, UBS said. $49 price target. Standing aside on opaque outlook.

First Energy downgraded at BMO from Outperform to Market Perform, BMO Capital said. $48 price target. Management has limited earnings visibility.

Fossil (FOSL) downgraded at Citigroup to Neutral from Buy, Citigroup said. $100 price target. Valuation call after rally on quarterly results.

Groupon (GRPN) downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Estimates also cut, as growth appears to be slowing.

Halliburton (HAL) upgraded to buy at TheStreet Ratings.

Jive Software (JIVE) downgraded at Citigroup to Neutral from Buy, Citigroup said. $21 price target. Thesis not playing out as fast as we'd hoped.

Jack Henry (JKHY) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Company has a strong balance sheet and the spending environment is improving.

MGE Energy (MGEE) upgraded at DA Davidson from Underperform to Neutral, DA Davidson said. Valuation call, based on a $48.50 price target.

MGM (MGM) downgraded to sell at TheStreet Ratings.

VeriFone (PAY) downgraded at UBS to Neutral from Buy, UBS said. $41 price target. Catalysts played out.

Par Pharmaceutical (PRX) downgrade at UBS to Neutral from Buy, UBS said. $58 price target. Valuation call given current TPG offer price.

Rackspace (RAX) upgraded at Pacific Crest to Outperform, Pacific Crest said. $62 price target. Company is realizing higher margins.

Sapient (SAPE) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Company is seeing slower growth in its Nitro segment.

Vectren (VVC) rated new Buy at Brean. $36 price target. Company has a solid yield and can deliver consistent growth over the long term.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs